Inventor · disambiguated record
Jun Pan
Also filed as: PAN JUN · PAN JUN-WU
30 granted patents·15 pending applications·246 citations·filing 2002–2024
97Inventor score
Files withINCYTE CORP36SYNNOVATION THERAPEUTICS INC3MICRO FOCUS LLC1RISEN SHANGHAI MEDICINAL TECH CO LTD1RISEN SUZHOU PHARMA TECH CO LTD1
Top patents by PatentIndex Score
45 records- 0197US11542265B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Jan 3, 2023·8 cites·43 claims
- 0297US11242343B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2020·Granted Feb 8, 2022·12 cites·27 claims
- 0396US10266530B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Granted Apr 23, 2019·24 cites·42 claims
- 0496US9580418B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Feb 28, 2017·19 cites·64 claims
- 0595US11891388B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Feb 6, 2024·3 cites·30 claims
- 0695US11780840B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Oct 10, 2023·4 cites·12 claims
- 0795US11731958B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2020·Granted Aug 22, 2023·4 cites·25 claims
- 0895US11406624B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 9, 2022·9 cites·16 claims
- 0995US10800761B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2019·Granted Oct 13, 2020·15 cites·12 claims
- 1094US10280164B2Pyrazolopyridone compounds and uses thereofINCYTE CORP·Filed 2017·Granted May 7, 2019·24 cites·38 claims
- 1194US10053465B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2016·Granted Aug 21, 2018·16 cites·37 claims
- 1294US9676750B2Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 13, 2017·18 cites·53 claims
- 1393US12384778B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2023·Granted Aug 12, 2025·1 cites·49 claims
- 1493US11795166B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 24, 2023·2 cites·26 claims
- 1593US11136326B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2019·Granted Oct 5, 2021·6 cites·31 claims
- 1693US9278950B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Mar 8, 2016·24 cites·55 claims
- 1792US11767323B2Tricyclic pyridone compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Sep 26, 2023·3 cites·37 claims
- 1892US11014929B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted May 25, 2021·12 cites·54 claims
- 1992US10000507B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·12 cites·18 claims
- 2091US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 2188US11840546B2Imidazopyridazine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Dec 12, 2023·1 cites·8 claims
- 2286US10519163B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2018·Granted Dec 31, 2019·4 cites·38 claims
- 2383US12187725B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2023·Granted Jan 7, 2025·0 cites·42 claims
- 2483US11459329B2Imidazopyridazine and imidazopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Oct 4, 2022·3 cites·61 claims
- 2581US2025320212A1Tricyclic urea compounds as jak2 v617f inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2678US12030889B2Imidazopyridazine and imidazopyridine compounds and uses thereofINCYTE CORP·Filed 2022·Granted Jul 9, 2024·0 cites·12 claims
- 2777US12466815B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·66 claims
- 2877US2024309008A1Imidazopyridazine and imidazopyridine compounds and uses thereofINCYTE CORP·Filed 2024·Application pending·0 cites
- 2976US11229631B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2020·Granted Jan 25, 2022·0 cites·4 claims
- 3075US2024083918A1Imidazopyridazine compounds and uses thereofINCYTE CORP·Filed 2023·Application pending·0 cites
- 3169US2025170161A1Inhibin subunit beta e inhibitor and methods of use thereofRISEN SHANGHAI MEDICINAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 3265US7005426B2Folic acid-polysaccharide complex, its preparation method and pharmaceutical composition containing the same as active componentUNIV FUDAN·Filed 2002·Granted Feb 28, 2006·3 cites·17 claims
- 3365US2019315743A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Application pending·0 cites
- 3461US2025270213A1PI3Ka INHIBITORSSYNNOVATION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3561US2025171444A1PI3Ka INHIBITORSSYNNOVATION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3660US2025163022A1Parp1 inhibitorsSYNNOVATION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3760US2018072718A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 3859US2023019098A1Bivalent compounds, conjugates and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 3958US2025333730A1Sirna for inhibiting angptl3 gene expression and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 4056US9890162B2Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2017·Granted Feb 13, 2018·0 cites·70 claims
- 4153US2018072741A1Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 4250US2025085992A1Discover and model applications deployed in containerized platformsMICRO FOCUS LLC·Filed 2023·Application pending·0 cites
- 4349US2018228786A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Application pending·0 cites
- 4447US2021340252A1Anti-tim-3 antibodies and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2019·Application pending·0 cites
- 4538US10723705B2Heterocyclic compounds and uses thereofINCYTE CORP·Filed 2016·Granted Jul 28, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Jun Pan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →